The Journal of Immunology, Vol 142, Issue 9 3091-3097, Copyright © 1989 by American Association of Immunologists

ARTICLES

HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection

KJ Weinhold, HK Lyerly, SD Stanley, AA Austin, TJ Matthews and DP Bolognesi
Department of Surgery, Duke University Medical Center, Durham, NC 27710.

The magnitude of immunologic defects observed in HIV-1-infected individuals before the development of overt AIDS is disproportionately high in comparison to the levels of infectious virus in these patients-- suggesting that factors other than direct virus-induced cytopathology may be involved. With this in mind, we investigated the immunologic consequences of the interaction between purified HIV-1 gp120 and the CD4 molecules expressed by uncommitted as well as Ag-specific lymphocytes. HIV-1 gp120 exhibited a dose-dependent immunosuppressive effect on: 1) Ag-driven proliferation of cloned CD4+ lymphocytes, 2) OKT3-driven proliferation of cloned CD4+ lymphocytes, and 3) cytolytic activity of CD4+, EBV-specific CTL. Thus, HIV-1 gp120 can, in a manner similar to OKT4A antibodies, suppress T cell activation and the expression of cytolytic activities through its interaction with CD4. Additionally, activated CD4+ lymphoblasts can be rendered susceptible to immune cytolysis by virtue of their binding of purified gp120. This "targeting" of activated lymphoblasts can occur with levels of gp120 far below that which is needed to saturate all OKT4A-defined CD4 epitopes. Adsorbed gp120 could be demonstrated on the surface of these cells for up to 12 h, a sufficient time for interaction with host cytolytic elements. The data from these in vitro modeling experiments highlight one of many potential mechanisms of HIV-1 induced immunosuppression and lymphocyte destruction that can occur in the absence of infectious virus and that is based on the unique interaction between HIV-1 gp120 and its cellular receptor, CD4.

This article has been cited by other articles:

				A. M. Nyakeriga, C. J. Fichtenbaum, J. Goebel, S. A. Nicolaou, L. Conforti, and C. A. Chougnet Engagement of the CD4 Receptor Affects the Redistribution of Lck to the Immunological Synapse in Primary T Cells: Implications for T-Cell Activation during Human Immunodeficiency Virus Type 1 Infection J. Virol., February 1, 2009; 83(3): 1193 - 1200. [Abstract] [Full Text] [PDF]

				L. Stevceva, V. Yoon, A. Carville, B. Pacheco, M. Santosuosso, B. Korioth-Schmitz, K. Mansfield, and M. C. Poznansky The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo J. Immunol., October 15, 2008; 181(8): 5510 - 5521. [Abstract] [Full Text] [PDF]

				H. Horton, T. U. Vogel, D. K. Carter, K. Vielhuber, D. H. Fuller, T. Shipley, J. T. Fuller, K. J. Kunstman, G. Sutter, D. C. Montefiori, et al. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 J. Virol., June 14, 2002; 76(14): 7187 - 7202. [Abstract] [Full Text] [PDF]

				C. Cicala, J. Arthos, A. Rubbert, S. Selig, K. Wildt, O. J. Cohen, and A. S. Fauci HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells PNAS, February 1, 2000; 97(3): 1178 - 1183. [Abstract] [Full Text] [PDF]

				S. L. Kozak, S. E. Kuhmann, E. J. Platt, and D. Kabat Roles of CD4 and Coreceptors in Binding, Endocytosis, and Proteolysis of gp120 Envelope Glycoproteins Derived from Human Immunodeficiency Virus Type 1 J. Biol. Chem., August 13, 1999; 274(33): 23499 - 23507. [Abstract] [Full Text] [PDF]

				N. Meller, A. Altman, and N. Isakov New Perspectives on PKC{theta}, a Member of the Novel Subfamily of Protein Kinase C Stem Cells, May 1, 1998; 16(3): 178 - 192. [Abstract] [Full Text]

				L. Flamand, R. W. Crowley, P. Lusso, S. Colombini-Hatch, D. M. Margolis, and R. C. Gallo Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: Implications for HIV pathogenesis PNAS, March 17, 1998; 95(6): 3111 - 3116. [Abstract] [Full Text] [PDF]

				T. Kion and G. Hoffmann Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice Science, September 6, 1991; 253(5024): 1138 - 1140. [Abstract] [PDF]

				R. Finberg, D. Diamond, D. Mitchell, Y Rosenstein, G Soman, T. Norman, S. Schreiber, and S. Burakoff Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120 Science, July 20, 1990; 249(4966): 287 - 291. [Abstract] [PDF]

				D Lamarre, A Ashkenazi, S Fleury, D. Smith, R. Sekaly, and D. Capon The MHC-binding and gp120-binding functions of CD4 are separable Science, August 18, 1989; 245(4919): 743 - 746. [Abstract] [PDF]